UB Paderborn / Katalog / Suche / in CDI

Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism

Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9418-9444

2023

Volltextzugriff (PDF)

Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models: Discovery and preclinical characterization of LL-00084282

Biochemical and biophysical research communications, 2022-12, Vol.637, p.267-275

2022

Volltextzugriff (PDF)

Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis

European journal of pharmacology, 2022-07, Vol.927, p.175054-175054, Article 175054

2022

Volltextzugriff (PDF)

Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate

Journal of medicinal chemistry, 2019-12, Vol.62 (23), p.10563-10582

2019

Volltextzugriff (PDF)

Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure–Activity Relationship and Preclinical Characterization

Journal of medicinal chemistry, 2020-02, Vol.63 (3), p.944-960

2020

Volltextzugriff (PDF)

LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization

European journal of pharmacology, 2021-01, Vol.891, p.173685-173685, Article 173685

2021

Volltextzugriff (PDF)

Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro‑N‑(2′-methyl-3′-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1′-biphenyl]-4-yl)benzamide. Structure–Activity Relationship and Preclinical Characterization

Journal of medicinal chemistry, 2021-12, Vol.64 (23), p.17004-17030

2021

Volltextzugriff (PDF)

Discovery of a Potent and Selective PI3Kδ Inhibitor (S)‑2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl‑4H‑quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models

Journal of medicinal chemistry, 2020-12, Vol.63 (23), p.14700-14723

2020

Volltextzugriff (PDF)

Discovery of a Potent and Selective PI3Kδ Inhibitor ( S )-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4 H -quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models

Journal of medicinal chemistry, 2020-12, Vol.63 (23), p.14700-14723

2020

Volltextzugriff (PDF)

Discovery of Potent, Selective, and State-Dependent Na V 1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides

Journal of medicinal chemistry, 2020-06, Vol.63 (11), p.6107-6133

2020

Volltextzugriff (PDF)

Performance analysis of voice and data transmission on a conflict free local area network

Mehta, Maneesh

1983

Volltextzugriff (PDF)

Business by bytes

Ivey business journal, 1998-07, Vol.62 (4), p.32

1998

Volltextzugriff (PDF)

Mind over matter: technology is driving us from a material to a knowledge economy and changing our understanding of product value in the process

Ivey business journal, 1998-04, Vol.62 (3), p.26

1998

Volltextzugriff (PDF)

Mind over matter

Ivey business journal, 1998-04, Vol.62 (3), p.26

1998

Volltextzugriff (PDF)

Acknowledging DSMA with priority scheduling for local area networks

Computer communication review, 1983-04, Vol.13 (2), p.226-231

1983

Volltextzugriff (PDF)

Acknowledging DSMA with priority scheduling for local area networks

Applications, Technologies, Architectures, and Protocols for Computer Communication: Proceedings of the symposium on Communications Architectures & Protocols; 08-09 Mar. 1983, 1983, p.226-231

1983

Volltextzugriff (PDF)

Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction

Digestive diseases and sciences, 2021-12, Vol.66 (12), p.4169-4177

2021

Volltextzugriff (PDF)

The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series

PLoS neglected tropical diseases, 2018-02, Vol.12 (2), p.e0006212-e0006212

2018

Volltextzugriff (PDF)

Guidelines for the management of ocular trauma during the COVID-19 pandemic

Indian journal of ophthalmology, 2020-11, Vol.68 (11), p.2483-2485

2020

Volltextzugriff (PDF)

Tu1089 Admissions for Acute Pancreatitis But Not Inflammatory Bowel Disease Follow a Seasonal Pattern and Are More Common in Summer

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S838-S839

2016

Volltextzugriff (PDF)

Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Inflammatory bowel diseases, 2015-11, Vol.21 (11), p.2696-2707

2015

Volltextzugriff (PDF)

Immunological and Hemato-biochemical alterations in diarrhoeic buffaloes screened for Mycobacterium avium subspecies paratuberculosis infection using ‘indigenous ELISA kit’

Comparative immunology, microbiology and infectious diseases, 2022-08, Vol.87, p.101833-101833, Article 101833

2022

Volltextzugriff (PDF)

P-023 Increased Risk of Opportunistic Infections in Ulcerative Colitis Patients Undergoing Hematopoietic Stem Cell Transplant

Inflammatory bowel diseases, 2016-03, Vol.22, p.S16

2016

Volltextzugriff (PDF)

Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study

Lancet neurology, 2020-10, Vol.19 (10), p.826-839

2020

Volltextzugriff (PDF)

Corrigendum to “Immunological and hemato-biochemical alterations in diarrhoeic buffaloes screened for Mycobacterium avium subspecies paratuberculosis infection using 'indigenous ELISA kit'” [Comp. Immunol. Microbiol. Infect. Dis. 87 (2022) 101833]

Comparative immunology, microbiology and infectious diseases, 2022-08, Vol.87, p.101852-101852, Article 101852

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism

Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models: Discovery and preclinical characterization of LL-00084282

Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis

Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate

Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure–Activity Relationship and Preclinical Characterization

LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization

Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro‑N‑(2′-methyl-3′-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1′-biphenyl]-4-yl)benzamide. Structure–Activity Relationship and Preclinical Characterization

Discovery of a Potent and Selective PI3Kδ Inhibitor (S)‑2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl‑4H‑quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models

Discovery of a Potent and Selective PI3Kδ Inhibitor ( S )-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4 H -quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models

Discovery of Potent, Selective, and State-Dependent Na V 1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides

Performance analysis of voice and data transmission on a conflict free local area network

Business by bytes

Mind over matter: technology is driving us from a material to a knowledge economy and changing our understanding of product value in the process

Mind over matter

Acknowledging DSMA with priority scheduling for local area networks

Acknowledging DSMA with priority scheduling for local area networks

Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction

The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series

Guidelines for the management of ocular trauma during the COVID-19 pandemic

Tu1089 Admissions for Acute Pancreatitis But Not Inflammatory Bowel Disease Follow a Seasonal Pattern and Are More Common in Summer

Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Immunological and Hemato-biochemical alterations in diarrhoeic buffaloes screened for Mycobacterium avium subspecies paratuberculosis infection using ‘indigenous ELISA kit’

P-023 Increased Risk of Opportunistic Infections in Ulcerative Colitis Patients Undergoing Hematopoietic Stem Cell Transplant

Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study

Corrigendum to “Immunological and hemato-biochemical alterations in diarrhoeic buffaloes screened for Mycobacterium avium subspecies paratuberculosis infection using 'indigenous ELISA kit'” [Comp. Immunol. Microbiol. Infect. Dis. 87 (2022) 101833]

Suchergebnisse filtern